MedPath

Study to Evaluate the Efficacy and Safety of Telmisartan/Amlodipine/Rosuvastatin

Phase 3
Completed
Conditions
Dyslipidemia With Hypertension
Interventions
Drug: Group I (Telmisartan 80 mg, Amlodipine 10 mg, Rosuvastatin 20 mg)
Drug: Group II (Telmisartan 80 mg, Amodipine 10 mg, Rosuvastatin placebo)
Drug: Group III (Telmisartan 80 mg, Amlodipine placebo, Rosuvastatin 20 mg)
Registration Number
NCT03088254
Lead Sponsor
Jeil Pharmaceutical Co., Ltd.
Brief Summary

To evaluate efficacy and safety of co-administrated temisartan/amlodipine and rosuvastatin in subjects with dyslipidemia with hypertension.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
126
Inclusion Criteria
  • Dyslipidemia with hypertesion
  • msSBP < 180 mmHg
  • msDBP < 110 mmHg
  • LDL-C ≤ 250 mg/dL
  • Triglycerides < 400 mg/dL
Exclusion Criteria
  • At Visit 3, BP difference SBP ≥20mmHg or DBP ≥10mmHg
  • CK normal range ≥ 2 times
  • Uncontrolled primary hypothyroidism(TSH normal range ≥ 1.5 times)
  • AST or ALT ≥ 2 times
  • Uncontrolled diabetes mellitus (HbA1c≥9%)
  • CLcr < 30 mL/min/1.73m^2
  • K > 5.5 mEq/L
  • Other exclusion applied

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Group IGroup I (Telmisartan 80 mg, Amlodipine 10 mg, Rosuvastatin 20 mg)Treatment of Telmisartan 80 mg, Amodipine 10 mg, Rosuvastatin 20 mg for 8 weeks
Group IIGroup II (Telmisartan 80 mg, Amodipine 10 mg, Rosuvastatin placebo)Treatment of Telmisartan 80 mg, Amodipine 10 mg, Rosuvastatin placebo for 8 weeks
Group IIIGroup III (Telmisartan 80 mg, Amlodipine placebo, Rosuvastatin 20 mg)Treatment of Telmisartan 80 mg, Amodipine placebo, Rosuvastatin 20 mg for 8 weeks
Primary Outcome Measures
NameTimeMethod
change of LDL-Cbaseline and 8 weeks
change of msSBPbaseline and 8 weeks
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (12)

Ewha Womans University Mokdong Hospital

🇰🇷

Seoul, Korea, Republic of

Kangbuk Samsung Hospital

🇰🇷

Seoul, Korea, Republic of

Korea University Anam Hospital

🇰🇷

Seoul, Korea, Republic of

Chungnam National University Hospital

🇰🇷

Daejeon, Korea, Republic of

Seoul National University Hospital

🇰🇷

Seoul, Korea, Republic of

Gachon University Gil Medical Center

🇰🇷

Incheon, Korea, Republic of

Seoul National University Bundang Hospital

🇰🇷

Gyeonggi-do, Korea, Republic of

Inje University Haeundae Paik Hospital

🇰🇷

Pusan, Korea, Republic of

SoonChunHyang University Hospital, Seoul

🇰🇷

Seoul, Korea, Republic of

The Catholic University of Korea Seoul St. Mary's Hospital

🇰🇷

Seoul, Korea, Republic of

Chonnam National University Hospital

🇰🇷

Gwangju, Korea, Republic of

KyungHee University Hospital at Gangdong

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath